Discover
ACXP
Acurx Pharmaceuticals, Inc.
1.47
2 x 1.47
2 x 1.48
bid
ask
-
0.06
3.92%
50 @ 04:00 PM
1.49 +0.02 (1.36%)
| Ytd | -40.96% | |
| 1y | -67.19% |
1.47
day range
1.63
1.33
52 week range
8.34
| Open | 1.58 | Prev Close | 1.53 | Low | 1.47 | High | 1.63 | Mkt Cap | 6.32M |
| Vol | 0.00 | Avg Vol | 93.97K | EPS | -4.05 | P/E | -0.36 | Forward P/E | -0.56 |
| Beta | -1.72 | Short Ratio | 12.59 | Inst. Own | 11.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.55 | 200-d Avg | 2.78 | 1yr Est | 11.19 |
| Income Statement | |||
| Operating Expenses | 1.72M | ||
| Research and Development Expense | 341.47K | ||
| Selling, General and Administrative Expense | 1.37M | ||
| Operating Income | -1.72M | ||
| Net Income | -1.68M | ||
| Net Income Common Stock | -1.68M | ||
| Net Income Common Stock (USD) | -1.68M | ||
| Consolidated Income | -1.68M | ||
| Earnings per Basic Share | -0.62 | ||
| Earnings per Basic Share (USD) | -0.62 | ||
| Earnings per Diluted Share | -0.62 | ||
| Earning Before Interest & Taxes (EBIT) | -1.68M | ||
| Earning Before Interest & Taxes (USD) | -1.68M | ||
| Weighted Average Shares | 2.72M | ||
| Weighted Average Shares Diluted | 2.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.25M | ||
| Cash and Equivalents (USD) | 9.25M | ||
| Trade and Non-Trade Receivables | 56.31K | ||
| Current Assets | 9.54M | ||
| Total Assets | 9.54M | ||
| Current Liabilities | 2.53M | ||
| Total Liabilities | 2.53M | ||
| Accumulated Retained Earnings (Deficit) | -76.97M | ||
| Shareholders Equity | 7.01M | ||
| Shareholders Equity (USD) | 7.01M | ||
| Trade and Non-Trade Payables | 2.53M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 3.11M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.70M | ||
| Issuance (Purchase) of Equity Shares | 3.11M | ||
| Net Cash Flow from Operations | -1.41M | ||
| Share Based Compensation | 258.29K | ||